Literature DB >> 14962205

Bleeding manifestations in males with von Willebrand disease.

O Ziv1, M V Ragni.   

Abstract

von Willebrand disease (vWD) is the most common congenital bleeding disorder in the USA, affecting 1-3% of the population. Previously characterizing the bleeding symptoms in females with type 1 vWD, we evaluated 42 males with type 1 vWD, mean age 16 years (1-64), of whom 24 (57%) presented with bleeding symptoms. The most common initial symptom was postoperative bleeding (26%). The most common bleeding symptoms ever were epistaxis (53%), bruising (50%), postoperative bleeding (47%), haematomas (29%) and oral bleeding (29%). Of postoperative bleeding, ear/nose/throat (44%), dental (17%) and circumcision bleeding (22%) occurred at a median 10 years of age, despite a previous bleeding or family history in 89%. Complications included anaemia in five (12%), neurological sequelae after subdural haematoma and tonsillectomy in two (5%), transfusion-associated hepatitis C in two (5%) and degenerative joint disease after traumatic haemarthroses in one (2%). The bleeding time (BT) was prolonged in 83%, and the ristocetin cofactor (vW:RCoF) and factor VIII (FVIII:C) decreased in 64% and 43%, respectively. Haemarthroses and haematoma formation were associated with a longer activated partial thromboplastin time (APTT) (P < 0.05), and anaemia with a lower FVIII:C (P < 0.05). In 81%, a haemostatic response occurred with 1-8 deamino-d-arginine vasopressin (DDAVP), although, in 13%, surgical intervention was also required to achieve haemostasis. Postoperative bleeding could have been avoided in 89%, if a preoperative past bleeding history or family history had been obtained, and, in at least 94%, if a preoperative BT and APTT had also been performed. The failure to avoid postoperative bleeding and related complications in patients with vWD by taking a personal and family bleeding history constitutes a major public health problem.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962205     DOI: 10.1111/j.1365-2516.2003.00871.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

Review 1.  [Current aspects in epistaxis].

Authors:  B J Folz; M Kanne; J A Werner
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

Review 2.  von Willebrand's disease diagnosis and laboratory issues.

Authors:  G Castaman; R R Montgomery; S S Meschengieser; S L Haberichter; A I Woods; M A Lazzari
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

3.  An infant with subdural hematoma and retinal hemorrhages: does von Willebrand disease explain the findings?

Authors:  Arne Stray-Pedersen; Sigrid Omland; Bård Nedregaard; Sjur Klevberg; Torleiv Ole Rognum
Journal:  Forensic Sci Med Pathol       Date:  2010-07-01       Impact factor: 2.007

4.  [The significance of bleeding disorders in patients with epistaxis].

Authors:  T Taeumer; A de Greiff; I Scharrer; K Papaspyrou; T Mewes; W Mann
Journal:  HNO       Date:  2011-06       Impact factor: 1.284

5.  Relevance of Abusive Head Trauma to Intracranial Hemorrhages and Bleeding Disorders.

Authors:  James D Anderst; Shannon L Carpenter; Rodney Presley; Molly Curtin Berkoff; Allison P Wheeler; Robert F Sidonio; J Michael Soucie
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

6.  Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.

Authors:  Youssef Al Tonbary; Rasha Elashry; Maysaa El Sayed Zaki
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

7.  Von Willebrand disease combined with coagulation defects in Iran.

Authors:  Omid Seidizadeh; Minoo Ahmadinejad; Sanaz Homayoun; Pier Mannuccio Mannucci; Flora Peyvandi
Journal:  Blood Transfus       Date:  2021-05-28       Impact factor: 3.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.